Literature Review of Nursing Intervention Studies for Patients Undergoing Percutaneous Coronary Intervention

Bleeding in Patients Undergoing Percutaneous Coronary Intervention

Effect of Jacobson's relaxation on anxiety in patients undergoing percutaneous coronary intervention

Introduction: Anxiety is common in patients undergoing percutaneous coronary intervention. Some studies have shown that one of the decreasing factors in anxiety is relaxation. Importantly, this study has been done with the aim of investigate the effect of Jacobson's relaxation on anxiety in patients undergoing percutaneous coronary intervention. Materials and Methods: In this double-blind clini...

Association of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in Iranian Patients undergoing Percutaneous Coronary Intervention

Clopidogrel is an antiplatelet agent currently used for preventing stent thrombosis. Despite certain clinical benefits of clopidogrel in patients undergoing percutaneous coronary intervention (PCI), adequate antiplatelet effect has not been obtained in some patients. The present study was designed to investigate the potential association of ABCB1 (ATP-Binding Cassette, Subfamily B, member1) gen...

Effect of Aromatherapy Massage on Anxiety among Patients Undergoing Percutaneous Coronary Intervention

Background and Objective: Percutaneous Coronary Intervention (PCI) is a common procedure in treatment of coronary artery diseases. Anxiety is a common psychological reaction to cardiovascular interventions. Anxiety can affect physiological responses and cause blood pressure increase, cardiac output decrease, cardiac o2 demand increase, and finally ischemic pain. The aim of this study was to ass...

Clopidogrel Resistance and its Impact on Clinical Outcome of Iranian Patients Undergoing Percutaneous Coronary Intervention

The aim of current study was evaluating the frequency of clopidogrel resistance and its impact on clinical outcome of patients in Iranian patients. Patients undergoing percutaneous coronary intervention in Imam Hussein Medical center, Tehran, Iran, who received standard dosage of clopidogrel (Plavix®, Sanofi, France, 600 mg loading dose and 75 mg/day afterward) were recruited. Platelet aggregat...